C12N 2760/12151
Methods of production or purification of viral material
C12N2760/12151 (Methods of production or purification of viral material) appears on 5 US grants and 6 published applications in this corpus.
Search patents in C12N- Granted patents
- 5
- Published applications
- 6
- Assignees
- 7
- Inventors
- 9
- Latest grant
- 26 Oct 2021
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1993 | 1 | 0 |
| 1994 | 0 | 0 |
| 1995 | 0 | 0 |
| 1996 | 0 | 0 |
| 1997 | 0 | 0 |
| 1998 | 0 | 0 |
| 1999 | 0 | 0 |
| 2000 | 0 | 0 |
| 2001 | 0 | 0 |
| 2002 | 0 | 0 |
| 2003 | 0 | 0 |
| 2004 | 0 | 0 |
| 2005 | 0 | 0 |
| 2006 | 0 | 0 |
| 2007 | 0 | 0 |
| 2008 | 0 | 0 |
| 2009 | 0 | 0 |
| 2010 | 0 | 0 |
| 2011 | 0 | 1 |
| 2012 | 0 | 0 |
| 2013 | 0 | 0 |
| 2014 | 0 | 1 |
| 2015 | 1 | 0 |
| 2016 | 1 | 1 |
| 2017 | 0 | 0 |
| 2018 | 0 | 0 |
| 2019 | 1 | 0 |
| 2020 | 0 | 1 |
| 2021 | 1 | 0 |
| 2022 | 0 | 2 |
By publication year. Applications have been published since 2001.
Subgroups
Granted patents
Recent patents
- Sin Nombre virus full-length M segment-based DNA vaccines26 Oct 2021US 11,155,834 B2The Government of the United States, as represented by the Secretary of the Army
- Sin Nombre virus full-length M segment-based DNA vaccines15 Oct 2019US 10,443,073 B2The Government of the United States, as represented by the Secretary of the Army
- Nucleic acids containing a synthetic codon-optimized Sin Nombre virus full-length M gene19 Apr 2016US 9,315,826 B2The United States of America as rep. by the Sec'y of the Army, for U.S. Army Medical Research Institute of Infectious Diseases
- Methods of producing an antisense viral particle population30 Jun 2015US 9,068,160 B2
- Hantaan virus strain ROK84/105 and vaccine therefor2 Feb 1993US 5,183,658 AKorea Green Cross Corporation
- Hantavirus antigenic composition1 Sep 2022US 2022/0275346 A1Secretary of State for Health and Social Care
- Sin nombre virus full-length m segment-based dna vaccines24 Mar 2022US 2022/0090136 A1The Government of the United States, as represented by the Secretary of the Army
- Sin nombre virus full-length m segment-based dna vaccines2 Apr 2020US 2020/0102576 A1The Government of the United States, as represented by the Secretary of the Army
- Sin nombre virus full-length m segment-based dna vaccines1 Dec 2016US 2016/0346376 A1The United States of America, as rep. by the Sec'y of the Army, for U.S. Army Medical Research Insti
- Sin Nombre Virus Full-Length M Segment-Based DNA Vaccines20 Mar 2014US 2014/0079731 A1The United States of America as rep. by the Sec'y the army for U.S. Army Medical Research Institute
Most cited
By later US patents